Breast Cancer Research and Treatment

, Volume 40, Issue 1, pp 65–74 | Cite as

Variations in breast cancer treatment by patient and provider characteristics

  • John Z. Ayanian
  • Edward Guadagnoli
Guest editor's introduction

Summary

Guidelines for the optimal treatment of breast cancer have been publicized over the past 15 years, yet clinical practices continue to vary substantially in the United States. This article reviews the literature on variations in local and systemic treatment of breast cancer by patient and provider characteristics.

Studies of local therapy have consistently demonstrated that older women are less likely than younger women to receive radiation therapy after breast-conserving surgery. Some studies have noted that black women are less likely than white women to receive breast-conserving surgery and less likely to receive radiation therapy after breast-conserving surgery. Rates of breast-conserving surgery vary three-fold among geographic regions and between teaching and non-teaching hospitals. Patients at smaller hospitals appear less likely to receive indicated radiation therapy.

Patterns of systemic therapy have not been well described. Women over age 75 may not be receiving adequate hormonal therapy, but recent data are not available. Limited data suggest that rates of systemic therapy do not vary substantially by race or Hispanic ethnicity, but women without health insurance may not be receiving appropriate chemotherapy. Studies relating hospital and physician characteristics to the use of systemic therapy are sparse and inconclusive.

In order to increase the proportion of women who receive optimal treatment for breast cancer and ensure greater equity, a more sophisticated understanding of variations in clinical practice will be required. These variations may arise from insufficient knowledge of or disagreement with guidelines among physicians, inadequate communication between physicians and patients, and individual preferences or clinical attributes of patients. Future studies will need to explore the dialogue between women and their physicians that leads to decisions about treatment of breast cancer.

Key words

breast cancer treatment age race socioeconomic factors hospitals physician practice patterns 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kosecoff J, Kanouse DE, Brook RH: Changing practice patterns in the management of primary breast cancer: consensus development program. Health Serv Res 25:809–823, 1990PubMedGoogle Scholar
  2. 2.
    NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391–395, 1991Google Scholar
  3. 3.
    Samet J, Hunt WC, Key C, Humble CG, Goodwin JS: Choice of cancer therapy varies with age of patient. JAMA 255:3385–3390, 1986PubMedGoogle Scholar
  4. 4.
    Greenfield S, Blanco DM, Elashoff RM, Ganz PA: Patterns of care related to age of breast cancer patients. JAMA 257:2766–2770, 1987PubMedGoogle Scholar
  5. 5.
    Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104–110, 1994PubMedGoogle Scholar
  6. 6.
    Silliman RA, Guadagnoli F, Weitberg AB, Mor V: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44:M46–50, 1989PubMedGoogle Scholar
  7. 7.
    Lazovich D, White F, Thomas DB, Moe RE: Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433–3438, 1991PubMedGoogle Scholar
  8. 8.
    Farrow DC, Hunt WC, Samet JM: Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097–1101, 1992PubMedGoogle Scholar
  9. 9.
    Escarce JJ, Epstein KR, Colby DC, Schwartz JS: Racial differences in the elderly's use of medical procedures and diagnostic tests. Am J Public Health 83:948–954, 1993PubMedGoogle Scholar
  10. 10.
    Guadagnoli F, Ayanian JZ, Gibbons G, McNeil BJ, LoGerfo FW: The influence of race on the use of surgical procedures for treatment of peripheral vascular disease of the lower extremities. Arch Surg, in pressGoogle Scholar
  11. 11.
    Ayanian JZ: Heart disease in black and white. N Engl J Med 329:656–658, 1993PubMedGoogle Scholar
  12. 12.
    Ayanian JZ: Race, class, and the quality of medical care. JAMA 271:1207–1208, 1994PubMedGoogle Scholar
  13. 13.
    McWhorter WP, Mayer WJ: Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 77:1515–1517, 1987Google Scholar
  14. 14.
    Muss HB, Hunter CP, Wesley M, et al: Treatment plans for black and white women with stage II nodepositive breast cancer — The National Cancer Institute Black/White Cancer Survival Study experience. Cancer 70:2460–2467, 1992PubMedGoogle Scholar
  15. 15.
    Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS: Geographic variation in the use of breastconserving treatment for breast cancer. N Engl J Med 326:1102–1107, 1992PubMedGoogle Scholar
  16. 16.
    Osteen RT, Karnell LH: The National Cancer Data Base report on breast cancer. Cancer 73:1994–2000, 1994PubMedGoogle Scholar
  17. 17.
    Diehr P, Yergan J, Chu J, et al: Treatment modality and quality differences for black and white breast cancer patients treated in community hospitals. Med Care 27:942–958, 1989PubMedGoogle Scholar
  18. 18.
    Lipworth L, Abelin T, Connelly RR: Socio-economic factors in the prognosis of cancer patients. J Chron Dis 23:105–116, 1970PubMedGoogle Scholar
  19. 19.
    Berg JW, Ross R, Latourette HB: Economic status and survival of cancer patients. Cancer 39:467–477, 1977PubMedGoogle Scholar
  20. 20.
    Ayanian JZ, Kohler BA, Abe T, Epstein AM: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326–331, 1993PubMedGoogle Scholar
  21. 21.
    Hand R, Sener S, lmperato J, Chmiel JS, Sylvester J, Fremgen A: Hospital variables associated with quality of care for breast cancer patients. JAMA 266:3429–3432, 1991PubMedGoogle Scholar
  22. 22.
    Studnicki J, Schapira DV, Bradham DD, Clark RA, Jarrett A: Response to the National Cancer Institute alert — The effect of practice guidelines on two hospitals in the same medical community. Cancer 72:2986–2992, 1993PubMedGoogle Scholar
  23. 23.
    Lee-Feldstein A, Anton-Culver H, Feldstein PJ: Treatment differences and other prognostic factors related to breast cancer survival — Delivery systems and medical outcomes. JAMA 271:1163–1168, 1994PubMedGoogle Scholar
  24. 24.
    Deber RB, Thompson GG: Who still prefers aggressive surgery for breast cancer? Implications for the clinical applications of clinical trials. Arch Intern Med 147:1543–1547, 1987PubMedGoogle Scholar
  25. 25.
    McFall SL, Warnecke RB, Kaluzny AD, Aitken M, Ford L: Physician and practice characteristics associated with judgments about breast cancer treatment. Med Care 32:106–117, 1994PubMedGoogle Scholar
  26. 26.
    NIH Consensus Development Statement: Adjuvant chemotherapy of breast cancer — The NIH Consensus Development Panel. N Engl J Med 303:831–832, 1980Google Scholar
  27. 27.
    National Institutes of Health: Adjuvant chemotherapy for breast cancer. JAMA 254:3461–3463, 1985Google Scholar
  28. 28.
    McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326:1756–1761, 1992PubMedGoogle Scholar
  29. 29.
    Allen C, Cox EB, Manton KG, Cohen HJ: Breast cancer in the elderly — Current patterns of care. J Am Geriatr Soc 34:637–642, 1986PubMedGoogle Scholar
  30. 30.
    Chu J, Diehr P, Feigl P, et al: The effect of age on the care of women with breast cancer in community hospitals. J Gerontol 42:185–190, 1987PubMedGoogle Scholar
  31. 31.
    Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86:705–712, 1994PubMedGoogle Scholar
  32. 32.
    Berger D, Braverman A, Sohn CK, Morrow M: Patient compliance with aggressive multimodal therapy in locally advanced breast cancer. Cancer 61:1453–1456, 1988PubMedGoogle Scholar
  33. 33.
    Liberati A, Patterson WB, Biener L, McNeil BJ: Determinants of physicians' preferences for alternative treatments in women with early breast cancer. Tumori 73:601–609, 1987PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • John Z. Ayanian
    • 1
  • Edward Guadagnoli
    • 2
  1. 1.Department of MedicineDivision of General Medicine, Section on Health Services and Policy ResearchBrighamUSA
  2. 2.Women's Hospital and Harvard Medical School, and the Department of Health Care PolicyHarvard Medical SchoolBostonUSA

Personalised recommendations